Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ocugen Inc
(NQ:
OCGN
)
1.020
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ocugen Inc
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
When It Comes to Ocugen Stock I’m Damned If I Do or Don’t
June 06, 2021
After sprinting to $16.20 in early May, Ocugen’s fallen back to earth. What does it have to do to get OCGN stock back into double digits?
Via
InvestorPlace
This New Vaccine Market Could Be Bigger for Ocugen Than the U.S.
June 06, 2021
Ocugen is casting a wider net.
Via
The Motley Fool
Exposures
COVID-19
I Would Hope Inovio Isn’t Attracting ANY Serious Money
June 03, 2021
It seems as though INO stock will have a tough time getting and staying in double digits
Via
InvestorPlace
The Same Problems Persist for Ocugen in Marketing Covaxin
June 03, 2021
OCGN stock is attempting an upward move on unrealistic expectations. There is no reason to believe it can move upward in the long term.
Via
InvestorPlace
Exposures
COVID-19
28 Stocks Moving in Thursday's Pre-Market Session
June 03, 2021
Gainers GTT Communications, Inc. (NYSE: GTT) rose 41.6% to $3.54 in pre-market trading after jumping over 57% on Wednesday. Workhorse Group Inc. (NASDAQ: WKHS) rose 29.2% to $14...
Via
Benzinga
Why Ocugen's Stock Is Trading Higher Today
May 27, 2021
Ocugen (NASDAQ:OCGN) shares are trading higher a...
Via
Benzinga
Did the FDA Slam the Door on Ocugen's Chances of Winning Authorization for Covaxin?
June 03, 2021
The agency's revised emergency-authorization guidance for COVID-19 vaccines appears to present a significant hurdle for Ocugen.
Via
The Motley Fool
Exposures
COVID-19
Product Safety
FDA’s Vaccine Attitude, New Data Don’t Bode Well for Ocugen Stock
June 03, 2021
The FDA's recent warning that it could reject some applications for EUAs from vaccine makers does not portend well for Ocugen's aspirations. OCGN stock remains an excellent name to sell short.
Via
InvestorPlace
Exposures
COVID-19
Product Safety
10 Current And Former Penny Stocks With High Short Interest As BB & GME Stock Attract More Reddit Interest
June 03, 2021
Reddit stocks have surged thanks to big moves in BB and GME. With short interest as the focus, here are a few penny stocks to watch right now.
Via
Talk Markets
12 Health Care Stocks Moving In Wednesday's After-Market Session
June 02, 2021
Gainers Tilray (NASDAQ:TLRY) shares incre...
Via
Benzinga
How Risky Is Ocugen?
May 29, 2021
An EUA for its coronavirus vaccine candidate may be on the horizon.
Via
The Motley Fool
Exposures
COVID-19
Ocugen Stock Is a Speculative Covid-19 Vaccine Bet
May 28, 2021
OCGN stock is a speculative bet. An approval of Covaxin by the FDA would boost OCGN stock. However, the firm's revenue potential is limited.
Via
InvestorPlace
Exposures
COVID-19
Product Safety
12 Health Care Stocks Moving In Thursday's After-Market Session
May 27, 2021
Gainers Cellect Biotechnology (NASDAQ:APOP
Via
Benzinga
Why Ocugen Stock Is Moving Today
May 27, 2021
Ocugen Inc (NASDAQ: OCGN) shares gained 13.71% to $8.71 Thursday after the company announced it's on track to submit its Emergency Use Authorization application to the...
Via
Benzinga
Ocugen Stock Will Probably Drop Below $1
May 27, 2021
Ocugen will only make money from sales of its vaccine in the United States, but by the time that's possible, it'll be too late.
Via
InvestorPlace
Exposures
COVID-19
Take Your Ocugen Stock Profits and Run If You Haven’t Already
May 27, 2021
Though OCGN stock provided lifechanging profitability to speculators, these Cinderella stories usually come to a devastating end.
Via
InvestorPlace
Exposures
COVID-19
The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs
May 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26) I-Mab (NASDAQ: IMAB)...
Via
Benzinga
Exposures
COVID-19
OCGN Stock: The Big FDA News Lifting Ocugen Shares Today
May 27, 2021
OCGN stock is on the move today as biopharma Ocugen confirms its intent to submit an EUA for Covaxin in June 2021.
Via
InvestorPlace
Exposures
COVID-19
Product Safety
24 Stocks Moving in Thursday's Pre-Market Session
May 27, 2021
Gainers Vertex Energy, Inc. (NASDAQ: VTNR) rose 82% to $3.24 in pre-market trading after the company announced plans to acquire a Alabama refinery and related logistics assets....
Via
Benzinga
2 Reasons to Avoid Ocugen Stock -- and 1 Reason to Considering Buying It
May 27, 2021
The company has a path to success in the COVID-19 vaccine market, but it might be more of an uphill climb than some investors realize.
Via
The Motley Fool
Exposures
COVID-19
Here's What Is Going On With Ocugen (OCGN) Stock
May 27, 2021
Shares of Ocugen Inc. (NASDAQ: OCGN), India-based Bharat Biotech’s U.S. partner for COVID-19 vaccine Covaxin, fell 3.7% in Wednesday’s regular trading session. What...
Via
Benzinga
Exposures
COVID-19
FDA May Not Review New COVID-19 Vaccine Emergency Use Requests
May 26, 2021
The FDA, on Tuesday, said that it might decline to review and process new emergency use authorization (EUA) requests for COVID-19 vaccines for the rest of the pandemic...
Via
Benzinga
Exposures
COVID-19
Product Safety
Bharat Biotech's US Partner Ocugen Submits Covaxin Master File for FDA Review
May 25, 2021
Ocugen Inc (NASDAQ: OCGN), India-based Bharat Biotech’s U.S. partner for COVID-19 vaccine Covaxin, has submitted a “Master File” to the FDA...
Via
Benzinga
Exposures
COVID-19
Product Safety
Take Profits If You Own Ocugen Stock, but Now’s Not the Time to Buy
May 24, 2021
We don't know if the FDA will authorize emergency use for Covaxin. Therefore OCGN stock is a high risk investment.
Via
InvestorPlace
Exposures
Product Safety
Ocugen vs. Inovio: Where Is the Smart Money Going?
May 23, 2021
They're both seeking share in the vaccine market.
Via
The Motley Fool
Exposures
COVID-19
Ocugen Faces Long Odds Before Gaining From Its Covid-19 Support Role
May 21, 2021
Ocugen has skin in the Covid-19 vaccine game. But the company faces long odds on its partnership providing a long-term boost for OCGN stock.
Via
InvestorPlace
Exposures
COVID-19
Stay On The Sidelines With Ocugen Stock
May 19, 2021
The small biopharmaceutical company has a promising Covid-19 vaccine, but the timing of its approval remains a question mark for OCGN stock.
Via
InvestorPlace
Exposures
COVID-19
Ocugen Stock Is Left Behind As the U.S. Emerges From the Pandemic
May 17, 2021
There seems to be no need for Covaxin in the U.S. and there are no indications that the U.S. is considering approving it. Consequently, OCGN stock is worth shorting.
Via
InvestorPlace
Exposures
COVID-19
Will Covaxin's Success Against COVID Variants Make Ocugen a Big Winner?
May 15, 2021
It's still really early.
Via
The Motley Fool
Exposures
COVID-19
Ocugen or Vaxart: Which Will Take Investors Further?
May 15, 2021
These two high-flying biotechs are vying for the same market.
Via
The Motley Fool
Exposures
COVID-19
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.